Current medical treatment of ocular mucous membrane pemphigoid
B Sobolewska, C Deuter, M Zierhut - The ocular surface, 2013 - Elsevier
Ocular mucous membrane pemphigoid (MMP), as a potentially blinding disease, is an
indication for systemic immunosuppressive treatment. Immunosuppressive agents are
chosen with a “stepladder” approach, beginning with drugs having the fewest side effects.
Dapsone, sulfapyridine/sulfasalazine and azathioprine are less successful in controlling
inflammation than mycophenolate mofetil (MMF) and methotrexate (MTX). Moreover,
compared to other immunosuppressive agents, MMF, followed by MTX, has the lowest rate …
indication for systemic immunosuppressive treatment. Immunosuppressive agents are
chosen with a “stepladder” approach, beginning with drugs having the fewest side effects.
Dapsone, sulfapyridine/sulfasalazine and azathioprine are less successful in controlling
inflammation than mycophenolate mofetil (MMF) and methotrexate (MTX). Moreover,
compared to other immunosuppressive agents, MMF, followed by MTX, has the lowest rate …